Ongoing Studies

Eczema Study
(AnaptysBio, 24 Weeks)

Sadick Research Group is conducting a clinical study of adults receiving treatment for atopic dermatitis (eczema). 

Study Details

Phase: 2B
Gender: Male and Female
Minimum Age: 18 Years Old
Maximum Age: 75 Years Old
Facility Type: Outpatient
Stipend Range: Up to $550 ($55 per Completed Visit)
Study Length: 24 weeks
Sponsor: ApaptysBio, Inc.

Study Description

This is a 24-week randomized, double blind, placebo controlled, parallel group, dose ranging, Phase 2b study designed to assess the efficacy of different doses and dose regimens of Etokimab compared to placebo in adult subjects with moderate to severe atopic dermatitis (AD). This study will also assess the safety, tolerability, and pharmacokinetics of Etokimab. The study will have a total of 11 in-office visits (there is a 4-week screening period when some tests and assessments will be done to see if the study is suitable for you, followed by a 16-week treatment period, where you will attend the study center 8 times, then there will be an 8-week safety follow-up period, where you will attend the study center twice).Visits throughout the study include a physical exam, blood draws, urine sampling, ECG’s, assessments, and administration of study drug subcutaneously (SC) during selected onsite visits by qualified professionals and other assessments which will be reviewed in detail at your screening visit. All services are provided at no cost.

Inclusion and Exclusion Criteria

Eligible male and female adult participants between the ages of 18 to 75 years with a diagnosis of moderate to severe eczema for at least six months. Female subjects cannot plan to be pregnant or breast feeding during the study and male subjects must agree to use contraception during the study, and for at least 3 months after receiving the last does of study drug. Subjects must be available for the 11 office visits for the duration of the study and be willing to comply with all study instructions. Several other restrictions and criteria may apply that the study doctor will review with you to determine if you qualify to enter the study.

Other Trial Details

  • Physical exam and assessments of study condition to be provided at no cost by an experienced provider.
  • No insurance necessary.
  • Compensation will be provided at the end of study participation. 

PARTICIPATE IN THIS STUDY

Eczema Study (AnaptysBio, 24 Weeks)






Contact Information

Interested in our research? Join our newsletter

Send us a message

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt
Eczema treatment